PF-AtlasClinical Trials › NCT03898284

Impulse Oscillometry for Prognostication in Idiopathic Pulmonary Fibrosis

Impulse Oscillometry · Not specified

Registry ID
NCT03898284
Phase
Not specified
Status
Completed
Drug / intervention
Impulse Oscillometry
Sponsor
University Hospital, Tours
Start
2019-04-23
Enrollment
54
Locations
4

About this trial

A 5-point decline of forced vital capacity expressed as % predicted, over 6 months, is the current definition of disease progression (fast decline in lung function) in idiopathic pulmonary fibrosis. There is a need for techniques allowing to characterize disease progression earlier, so that treatment may be adapted as early as possible in the lack of a response. Hypothesis. Our hypothesis is that 3-month changes of lung function parameters measured by a novel technique, impulse oscillometry, predicts 6-month changes in forced vital capacity in idiopathic pulmonary fibrosis.

View NCT03898284 on ClinicalTrials.gov →

Explore related

Medical disclaimer. This page summarizes public trial data for NCT03898284 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.